Fundraising Fox

Genome

10 known investors

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions. It partners with hospitals and health systems, life sciences organizations, and genetic testing labs to expand patient access and improve care.

Also known as Genome Medical

Founders & leadership

MSMark Sylvester
Mark SylvesterChief Financial Officer
AWAndrew Warner
Andrew WarnerVice President, Product
MZMonica Zarb
Monica ZarbVice President, Business Development
DVDurand Van Arnem
Durand Van ArnemVice President, Engineering
AR
Alan RopeMedical Director

Investors · 10

Company profile

researched Aug 2026

Genome Medical is a telehealth-enabled genetic services company founded in 2016 that connects patients and their providers with genetic counselors, medical geneticists and physicians. Patients can schedule appointments without a provider referral and typically meet a board-certified genetic counselor within one week, via a 30-60 minute phone consultation. Clinicians review personal and family medical history, order genetic testing when medically appropriate (often using a mailed saliva collection kit, with most results returned in two to four weeks), and provide a results consultation plus a written summary the patient can share with their care team.

The company positions itself around rare disease care, describing a market in which patients often experience long diagnostic journeys and multiple misdiagnoses while new clinical trials and gene therapies emerge for previously untreatable conditions. Its service lines include genetic counseling, genetic test ordering, sponsored testing programs, patient recruitment for trials based on genetic eligibility criteria, and peer-to-peer genetics support for other clinicians. Patients may opt in to be notified about relevant clinical trial opportunities. Clinical coverage spans rare disease, cardiology, neurology, pediatrics and oncology, with named clinical leads for cancer, cardiovascular and pediatric, and neurology and adult genetic services.

Genome Medical describes itself as clinician-led and led by genetic counselors, with a care delivery technology platform supporting its services. GeneMatters is identified on the company's site as a Genome Medical company, with former GeneMatters clients and patients directed to log in through Genome Medical's website.

Founding story

The company was founded in 2016 on the premise that expert genetic guidance should be accessible to all, and is described as led by genetic counselors seeking to combine clinical genetics expertise with tech-enabled care delivery to close access gaps, particularly for patients with rare conditions.

Business model

Genome Medical sells genetic services both directly to patients and through organizational partners. Individuals can self-schedule telehealth genetic counseling; the company is an in-network provider with most commercial health insurance plans and bills insurance where applicable, while also offering self-pay and a financial assistance program. In parallel, it contracts with hospitals and health systems, life sciences and biopharmaceutical organizations, and genetic testing laboratories, delivering counseling, test ordering, sponsored testing programs, trial patient recruitment and peer-to-peer clinician support on their behalf. The company states it is lab- and test-agnostic and partners with most major genetic testing labs.

Revenue comes from patient consultations and partner contracts. A genetic counseling visit costs up to $250 depending on whether insurance or self-pay is used, with genetic testing billed separately and not included in the counseling fee. The company bills commercial insurers where in-network, using CPT codes 96041 and S0265; it states it does not accept government-affiliated plans such as Medicaid, Medicare or Tricare as primary or secondary insurance. Partner-side revenue derives from services provided to hospitals and health systems, life sciences organizations and genetic testing laboratories.

Traction

Reported metrics include over 250,000 total genetic counseling consults delivered, a 96% patient satisfaction rating, 148 million-plus covered lives, a team of more than 35 clinicians licensed across all 50 states, and genetic counselors with an average of over 10 years of experience. The company marked ten years of operation in a 2025-2026 anniversary campaign.

Latest developments

Recent company communications include a ten-year anniversary campaign on making genetics care accessible, publication of a white paper on inherited retinal diseases ("Voice of the Patient"), and new patient insights on rare epilepsy care. The site also notes the integration of GeneMatters as a Genome Medical company, including consolidated patient and client login.

Full profile — market position, technology, go-to-market, geography, history

Market position

The company describes itself as the leading provider of telehealth-enabled genetic services, differentiating on clinical depth in rare disease genetics. Reported scale includes more than 250,000 genetic counseling consults delivered, more than 35 clinicians, 148 million-plus covered lives and a 96% patient satisfaction rating.

Stated differentiators include being clinician- and genetic counselor-led; a multidisciplinary clinical team of genetic counselors, medical geneticists and primary care physicians averaging more than 10 years of experience; lab- and test-agnostic service delivery with most major genetic testing labs; appointment availability within one week without a referral; in-network status with most commercial insurance plans; nationwide coverage in all 50 states; and integration of clinical trial matching with counseling and testing.

Technology

The company delivers care through a telehealth and digital health technology platform that supports appointment scheduling, a patient portal for uploading prior genetic test results, phone-based consultations, test ordering workflows and results delivery. The platform enables provision of genetic services across all 50 states and supports identification of patients meeting genetic eligibility criteria for clinical trials.

Go-to-market

Genome Medical markets directly to consumers through self-scheduled, referral-free telehealth appointments and educational resources (blog articles, case studies, white papers, research and events), while pursuing B2B partnerships with hospitals and health systems, life sciences organizations and genetic testing labs. Published resources include a white paper on inherited retinal diseases and patient insights work on rare epilepsy care.

Two groups: individuals and families concerned about inherited or rare genetic conditions, including those with a known family mutation or existing test results, and who can self-refer; and institutional partners — hospitals and health systems, biopharmaceutical and life sciences organizations running trials and sponsored testing programs, and genetic testing laboratories seeking to add genetic services to their testing programs.

Geography

Genome Medical provides telehealth genetic services in all 50 U.S. states through its platform. Its rare disease framing references a global patient population of more than 300 million people, but service delivery described on its site is United States-based.

History

Founded in 2016, Genome Medical built a telehealth genetic services business led by genetic counselors. GeneMatters, another genetic counseling services provider, became a Genome Medical company, with GeneMatters clients and patients transitioned to Genome Medical's website and login. The company publicly celebrated ten years of operations, and its current leadership team is headed by CEO Jill Davies alongside a chief financial officer, chief clinical officer, vice presidents of product, strategy, business development and engineering, and clinical directors for cancer, cardiovascular and pediatric, and neurology and adult genetic services.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Average years of experience of genetic counselorsJan 202610 years
CliniciansJan 202635 clinicians
Covered livesJan 2026148,000,000 lives
Genetic counseling consults delivered (cumulative)Jan 2026250,000 consults
Genetic counseling visit price (maximum)Jan 2026$250
Patient satisfaction ratingJan 202696%
States servedJan 202650 US states

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 5

by search overlap
Labcorp470 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Invitae414 shared keywordsInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
Quest Diagnostics373 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Sequencing339 shared keywordsSequencing.com provides whole genome sequencing with a DNA collection kit and DNA reports offering health, wellness, and pharmacogenomic insights for consumers. It offers an optional subscription that reanalyzes a customer's genome monthly against the latest research and gives full access to raw and analyzed genetic data.
Myriad288 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.

Companies competing with Genome for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 3

launches, deals, and filings
Jan 2026
GeneMatters becomes a Genome Medical company

Genome Medical's website states that GeneMatters is now a Genome Medical company, with existing GeneMatters clients and patients directed to access their accounts through the Genome Medical site.

source ↗

Jan 2026
Genome Medical marks 10 years of operations

The company publicized a campaign celebrating 10 years of making genetics care accessible, and published a related news article.

source ↗

Jan 2026
Release of inherited retinal diseases white paper

Genome Medical published a 'Voice of the Patient' white paper on inherited retinal diseases, alongside new patient insights on rare epilepsy care.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 8

primary sources listed
  • Genomegenomemedical.com · web

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Genome do?
Genome Medical is a telehealth provider of genetic counseling, test ordering and clinical trial matching, focused on rare disease.
Who are Genome's investors?
Genome's investors include Canaan Partners, Dreamers VC, Echo Health Ventures, GV (Google Ventures), Illumina Ventures, Kaiser Permanente Ventures, Samsung Catalyst Fund, Walden Catalyst and 2 more.